707 related articles for article (PubMed ID: 30078747)
1. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
Kahles A; Lehmann KV; Toussaint NC; Hüser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; ; Rätsch G
Cancer Cell; 2018 Aug; 34(2):211-224.e6. PubMed ID: 30078747
[TBL] [Abstract][Full Text] [Related]
2. Integrative genome-wide analysis of the determinants of RNA splicing in kidney renal clear cell carcinoma.
Lehmann KV; Kahles A; Kandoth C; Lee W; Schultz N; Stegle O; Rätsch G
Pac Symp Biocomput; 2015; 20():44-55. PubMed ID: 25592567
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
Nejo T; Wang L; Leung KK; Wang A; Lakshmanachetty S; Gallus M; Kwok DW; Hong C; Chen LH; Carrera DA; Zhang MY; Stevers NO; Maldonado GC; Yamamichi A; Watchmaker PB; Naik A; Shai A; Phillips JJ; Chang SM; Wiita AP; Wells JA; Costello JF; Diaz AA; Okada H
Sci Rep; 2024 Mar; 14(1):6362. PubMed ID: 38493204
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
Nejo T; Wang L; Leung KK; Wang A; Lakshmanachetty S; Gallus M; Kwok DW; Hong C; Chen LH; Carrera DA; Zhang MY; Stevers NO; Maldonado GC; Yamamichi A; Watchmaker P; Naik A; Shai A; Phillips JJ; Chang SM; Wiita AP; Wells JA; Costello JF; Diaz AA; Okada H
bioRxiv; 2023 Nov; ():. PubMed ID: 37961484
[TBL] [Abstract][Full Text] [Related]
5. IDeAS: an interactive database for dysregulated alternative splicing in cancers across Chinese and western patients.
Zhou H; Yuan L; Ju Y; Hu Y; Wang S; Cao R; Wang Z; Zhang G
J Mol Cell Biol; 2024 Apr; 15(11):. PubMed ID: 38012117
[No Abstract] [Full Text] [Related]
6. Comprehensive Characterization of Cancer Driver Genes and Mutations.
Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B; Kwok-Shing Ng P; Jeong KJ; Cao S; Wang Z; Gao J; Gao Q; Wang F; Liu EM; Mularoni L; Rubio-Perez C; Nagarajan N; Cortés-Ciriano I; Zhou DC; Liang WW; Hess JM; Yellapantula VD; Tamborero D; Gonzalez-Perez A; Suphavilai C; Ko JY; Khurana E; Park PJ; Van Allen EM; Liang H; ; ; Lawrence MS; Godzik A; Lopez-Bigas N; Stuart J; Wheeler D; Getz G; Chen K; Lazar AJ; Mills GB; Karchin R; Ding L
Cell; 2018 Aug; 174(4):1034-1035. PubMed ID: 30096302
[No Abstract] [Full Text] [Related]
7. Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens.
Hoyos LE; Abdel-Wahab O
Cancer Cell; 2018 Aug; 34(2):181-183. PubMed ID: 30107172
[TBL] [Abstract][Full Text] [Related]
8. Intron retention is a source of neoepitopes in cancer.
Smart AC; Margolis CA; Pimentel H; He MX; Miao D; Adeegbe D; Fugmann T; Wong KK; Van Allen EM
Nat Biotechnol; 2018 Dec; 36(11):1056-1058. PubMed ID: 30114007
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations.
Lee SC; North K; Kim E; Jang E; Obeng E; Lu SX; Liu B; Inoue D; Yoshimi A; Ki M; Yeo M; Zhang XJ; Kim MK; Cho H; Chung YR; Taylor J; Durham BH; Kim YJ; Pastore A; Monette S; Palacino J; Seiler M; Buonamici S; Smith PG; Ebert BL; Bradley RK; Abdel-Wahab O
Cancer Cell; 2018 Aug; 34(2):225-241.e8. PubMed ID: 30107174
[TBL] [Abstract][Full Text] [Related]
10. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.
Korkut A; Zaidi S; Kanchi RS; Rao S; Gough NR; Schultz A; Li X; Lorenzi PL; Berger AC; Robertson G; Kwong LN; Datto M; Roszik J; Ling S; Ravikumar V; Manyam G; Rao A; Shelley S; Liu Y; Ju Z; Hansel D; de Velasco G; Pennathur A; Andersen JB; O'Rourke CJ; Ohshiro K; Jogunoori W; Nguyen BN; Li S; Osmanbeyoglu HU; Ajani JA; Mani SA; Houseman A; Wiznerowicz M; Chen J; Gu S; Ma W; Zhang J; Tong P; Cherniack AD; Deng C; Resar L; ; Weinstein JN; Mishra L; Akbani R
Cell Syst; 2018 Oct; 7(4):422-437.e7. PubMed ID: 30268436
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
Wang Y; Xu X; Maglic D; Dill MT; Mojumdar K; Ng PK; Jeong KJ; Tsang YH; Moreno D; Bhavana VH; Peng X; Ge Z; Chen H; Li J; Chen Z; Zhang H; Han L; Du D; Creighton CJ; Mills GB; ; Camargo F; Liang H
Cell Rep; 2018 Oct; 25(5):1304-1317.e5. PubMed ID: 30380420
[TBL] [Abstract][Full Text] [Related]
12. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Dijkstra KK; Cattaneo CM; Weeber F; Chalabi M; van de Haar J; Fanchi LF; Slagter M; van der Velden DL; Kaing S; Kelderman S; van Rooij N; van Leerdam ME; Depla A; Smit EF; Hartemink KJ; de Groot R; Wolkers MC; Sachs N; Snaebjornsson P; Monkhorst K; Haanen J; Clevers H; Schumacher TN; Voest EE
Cell; 2018 Sep; 174(6):1586-1598.e12. PubMed ID: 30100188
[TBL] [Abstract][Full Text] [Related]
13. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors.
Miao D; Margolis CA; Vokes NI; Liu D; Taylor-Weiner A; Wankowicz SM; Adeegbe D; Keliher D; Schilling B; Tracy A; Manos M; Chau NG; Hanna GJ; Polak P; Rodig SJ; Signoretti S; Sholl LM; Engelman JA; Getz G; Jänne PA; Haddad RI; Choueiri TK; Barbie DA; Haq R; Awad MM; Schadendorf D; Hodi FS; Bellmunt J; Wong KK; Hammerman P; Van Allen EM
Nat Genet; 2018 Sep; 50(9):1271-1281. PubMed ID: 30150660
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing in prostate cancer.
Paschalis A; Sharp A; Welti JC; Neeb A; Raj GV; Luo J; Plymate SR; de Bono JS
Nat Rev Clin Oncol; 2018 Nov; 15(11):663-675. PubMed ID: 30135575
[TBL] [Abstract][Full Text] [Related]
15. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Jiang P; Gu S; Pan D; Fu J; Sahu A; Hu X; Li Z; Traugh N; Bu X; Li B; Liu J; Freeman GJ; Brown MA; Wucherpfennig KW; Liu XS
Nat Med; 2018 Oct; 24(10):1550-1558. PubMed ID: 30127393
[TBL] [Abstract][Full Text] [Related]
16. Genetic and transcriptional evolution alters cancer cell line drug response.
Ben-David U; Siranosian B; Ha G; Tang H; Oren Y; Hinohara K; Strathdee CA; Dempster J; Lyons NJ; Burns R; Nag A; Kugener G; Cimini B; Tsvetkov P; Maruvka YE; O'Rourke R; Garrity A; Tubelli AA; Bandopadhayay P; Tsherniak A; Vazquez F; Wong B; Birger C; Ghandi M; Thorner AR; Bittker JA; Meyerson M; Getz G; Beroukhim R; Golub TR
Nature; 2018 Aug; 560(7718):325-330. PubMed ID: 30089904
[TBL] [Abstract][Full Text] [Related]
17. JUM is a computational method for comprehensive annotation-free analysis of alternative pre-mRNA splicing patterns.
Wang Q; Rio DC
Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8181-E8190. PubMed ID: 30104386
[TBL] [Abstract][Full Text] [Related]
18. Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis.
Braun S; Enculescu M; Setty ST; Cortés-López M; de Almeida BP; Sutandy FXR; Schulz L; Busch A; Seiler M; Ebersberger S; Barbosa-Morais NL; Legewie S; König J; Zarnack K
Nat Commun; 2018 Aug; 9(1):3315. PubMed ID: 30120239
[TBL] [Abstract][Full Text] [Related]
19. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
